These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5630622)

  • 1. Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.
    Day RM; Carroll FD
    Trans Am Ophthalmol Soc; 1967; 65():41-51. PubMed ID: 5630622
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.
    Day RM; Carroll FD
    Arch Ophthalmol; 1968 Mar; 79(3):279-82. PubMed ID: 5694289
    [No Abstract]   [Full Text] [Related]  

  • 3. Optic neuropathy of Graves disease, hyperthyroidism, and ocular myasthenia gravis.
    Cohen JS
    Arch Ophthalmol; 1973 Aug; 90(2):131-2. PubMed ID: 4352787
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior ischemic optic neuropathy in Graves' disease.
    Dosso A; Safran AB; Sunaric G; Burger A
    J Neuroophthalmol; 1994 Sep; 14(3):170-4. PubMed ID: 7804422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperthyroid atrial fibrillation associated with Graves disease by prednisone].
    Wei H; Li M; Qiu M
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):810-2. PubMed ID: 12126525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Compressive optic neuropathy and dysthyroidal ophthalmopathy. Therapeutic approach].
    Pelosse B; Chabolle F; Saraux H; Bouzas E
    Bull Soc Ophtalmol Fr; 1988 Feb; 88(2):201-3, 206. PubMed ID: 3214891
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery from pancytopaenia and liver dysfunction after administration of propylthiouracil for Graves' disease.
    Kebapcilar L; Yeşil S; Bayraktar F; Saklamaz A; Demir T; Güngör O; Alacacioglu I; Cömlekçi A
    N Z Med J; 2005 Aug; 118(1220):U1615. PubMed ID: 16132076
    [No Abstract]   [Full Text] [Related]  

  • 10. An informative case of Graves' disease with implications for schizophrenia.
    Adams DD; Knight JG; Manning P; Smith G
    J Clin Lab Immunol; 2004-2005; 53():13-25. PubMed ID: 16805322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elephantiasic pretibial myxoedema: study of five cases].
    Niang SO; Diallo M; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Dakar Med; 2007; 52(2):95-9. PubMed ID: 19102101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional disorders of the optic nerve in patients on oral contraceptives].
    Follmann P; Mucsi G; Varga K
    Klin Monbl Augenheilkd; 1973 May; 162(5):630-3. PubMed ID: 4353937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dysthyroid optic neuropathy. Apropos of 2 cases].
    Domenjôd M; Merle H; Gerard M; Ayeboua L; Poman G
    J Fr Ophtalmol; 1996; 19(8-9):543-50. PubMed ID: 8944137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmodynamometric measurement of orbital tissue pressure in thyroid-associated orbitopathy.
    Jonas JB
    Acta Ophthalmol Scand; 2004 Apr; 82(2):239. PubMed ID: 15043551
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic management of complicated ocular manifestations in Basedow disease].
    Le Jeunne C; Roujansky C; Hugues FC
    Ann Med Interne (Paris); 1996; 147(2):116-7. PubMed ID: 8760691
    [No Abstract]   [Full Text] [Related]  

  • 16. Endoscopic and transconjunctival orbital decompression for thyroid-related orbital apex compression.
    Schaefer SD; Soliemanzadeh P; Della Rocca DA; Yoo GP; Maher EA; Milite JP; Della Rocca RC
    Laryngoscope; 2003 Mar; 113(3):508-13. PubMed ID: 12616205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the active severe eye changes of Graves' disease.
    Werner SC
    Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Visual evoked potentials in diagnosis and monitoring of optic neuropathy in the course of thyroid ophthalmopathy].
    Rutecka-Debniak A; Lubiński W; Krzystolik Z
    Klin Oczna; 1999; 101(5):361-5. PubMed ID: 10714075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basedow's disease and thyroid nodules. A common association].
    Kraimps JL; Bouin-Pineau MH; Maréchaud R; Barbier J
    Ann Chir; 1998; 52(5):449-51. PubMed ID: 9752485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.